STOCK TITAN

Lazard Ltd Stock Price, News & Analysis

LAZ NYSE

Welcome to our dedicated page for Lazard news (Ticker: LAZ), a resource for investors and traders seeking the latest updates and insights on Lazard stock.

Lazard Ltd (LAZ) maintains its position as a global leader in financial advisory and asset management through strategic insights and operational excellence. This dedicated news hub provides investors with essential updates on corporate developments, market strategies, and financial performance.

Access authoritative reports on mergers & acquisitions, quarterly earnings disclosures, leadership changes, and regulatory filings. Our curated collection simplifies tracking LAZ's advisory engagements in restructuring and capital markets while monitoring its asset management division's international equity strategies.

Key updates include detailed analyses of cross-border transactions, institutional client partnerships, and operational expansions across 27 countries. Professionals rely on this resource for timely insights into LAZ's advisory role in complex corporate finance matters and its evolving position in global capital markets.

Bookmark this page for structured access to press releases and expert commentary. Regular updates ensure you remain informed about LAZ's strategic direction and industry impact without promotional bias.

Rhea-AI Summary

Lazard (NYSE:LAZ) has announced the appointment of Dr. Geoffrey Porges as Managing Director in its Healthcare Advisory Group. Dr. Porges brings over 30 years of experience in the biopharmaceutical industry, most recently serving as EVP and CFO at Schrödinger.

Prior to Schrödinger, Dr. Porges held notable positions including head of biopharma equity research at SVB Leerink and senior biotechnology analyst at Sanford C. Bernstein. He also served in senior roles at BTG PLC and Merck & Co. Dr. Porges holds a medical degree from the University of Sydney and an MBA from Harvard Business School as a Baker Scholar.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.9%
Tags
none
-
Rhea-AI Summary

Lazard (NYSE:LAZ) has announced a strategic expansion of its Nordic operations with the appointment of Jesper Jensen as Managing Director, Financial Advisory and CEO of Denmark, effective September 17, 2025. The company is establishing a new office in Denmark as part of this expansion.

Jensen brings over 25 years of experience and will work closely with Gustaf Slettengren and Victor Kastensson in Sweden to strengthen Lazard's presence in the Nordic region. He joins from Rothschild & Co and previously worked at JP Morgan in London. The appointment aligns with Lazard's 2030 strategic plan and aims to enhance the firm's ability to deliver global financial solutions to Nordic clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
none
-
Rhea-AI Summary

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of $258.4 billion for August 2025. The month saw market appreciation of $2.7 billion and FX appreciation of $2.2 billion, partially offset by net outflows of $0.2 billion.

The AUM breakdown includes $202.5 billion in Equity, $46.9 billion in Fixed Income, and $9.0 billion in Other assets. These figures represent increases across all categories compared to July 2025 levels.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
none
Rhea-AI Summary

Lazard (NYSE:LAZ) has announced the appointment of Christopher Hogbin as the new CEO of Lazard Asset Management, effective December 2025. Hogbin brings 30 years of professional experience, including 20 years at AllianceBernstein where he most recently served as Global Head of Investments.

Hogbin will succeed Evan Russo, who will transition to an advisory role after two decades at Lazard. During his tenure at AllianceBernstein, Hogbin played a crucial role in expanding investment capabilities across public and private markets and enhancing the firm's research function.

The appointment comes at what Lazard describes as an inflection point for their Asset Management business, with the company focusing on building momentum and meeting evolving client needs. Hogbin's expertise in growing global investment businesses aligns with Lazard's strategy for long-term growth and value creation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
-
Rhea-AI Summary

Lazard (NYSE:LAZ) has appointed Dmitry Shevelenko, Chief Business Officer of Perplexity, to its Board of Directors effective September 2, 2025. Shevelenko brings extensive technology leadership experience from roles at Uber, LinkedIn, and Meta, along with expertise in artificial intelligence and startup ventures.

The appointment aligns with Lazard's strategy to enhance its tech-enabled vision, combining AI-driven insights with human intellectual capital. CEO Peter R. Orszag emphasized that Shevelenko's AI leadership will advance the firm's future direction, while Lead Independent Director Dan Schulman highlighted the strategic importance of AI expertise in the company's governance and growth plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.36%
Tags
management AI
-
Rhea-AI Summary

Lazard Global Total Return and Income Fund (NYSE:LGI) has declared its monthly distribution of $0.14646 per share, payable on September 22, 2025, to shareholders of record on September 11, 2025. The distribution breakdown includes 21% from net income, 79% from capital gains, and no return of capital for the current distribution.

The Fund's performance metrics show a 9.46% average annual total return over the past 5 years and a 9.87% annualized distribution rate. The Fund's portfolio consists of 60-80 US and non-US equity securities, with investments in emerging markets currencies and debt obligations. As of July 31, 2025, Lazard Asset Management managed $253.7 billion in client assets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none
Rhea-AI Summary

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of $253.7 billion for July 2025. The month saw net inflows of $4.5 billion, market appreciation of $3.9 billion, and FX depreciation of $3.2 billion.

The AUM breakdown includes $198.8 billion in Equity, $46.0 billion in Fixed Income, and $8.9 billion in Other assets. Compared to June 2025, total AUM increased from $248.4 billion, primarily driven by growth in equity assets from $192.3 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.75%
Tags
none
-
Rhea-AI Summary

Lazard (NYSE:LAZ) has announced that its subsidiary Lazard Group LLC will redeem all outstanding 3.625% Senior Notes due March 1, 2027. The redemption will take place on September 18, 2025. The Notes, which have an outstanding principal amount of $97,027,000, were originally issued under an indenture dated May 10, 2005.

The redemption price will be calculated according to the make-whole provision in the Indenture. All interest on the Notes will cease to accrue from the redemption date. Noteholders are advised to contact their banks or brokers to obtain information about receiving the redemption payment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.75%
Tags
none
-
Rhea-AI Summary

Lazard (NYSE: LAZ) has announced the completion of its cash tender offer for its 3.625% Senior Notes due March 1, 2027. The tender offer, which expired on August 1, 2025, resulted in $202,944,000 in aggregate principal amount of Notes being validly tendered and accepted for purchase.

Holders of accepted notes will receive a Total Consideration of $991.89 per $1,000 principal amount, plus accrued and unpaid interest. Settlement is expected on August 4, 2025, with guaranteed delivery settlement on August 6, 2025. Citigroup Global Markets Inc. and Lazard Frères & Co. LLC served as dealer managers for the tender offer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
none
Rhea-AI Summary

Lazard (NYSE: LAZ) has successfully completed its offering of $300 million in senior notes due 2035 with a 5.625% interest rate. The notes, issued by Lazard Group LLC and guaranteed by Lazard, Inc., were offered through an effective shelf registration statement with the SEC.

The company plans to use the proceeds to repurchase all outstanding 3.625% Senior Notes due March 2027 through a cash tender offer expiring on August 1, 2025, at 5:00 p.m. (New York City time). Any remaining funds will be allocated for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags

FAQ

What is the current stock price of Lazard (LAZ)?

The current stock price of Lazard (LAZ) is $56.83 as of September 19, 2025.

What is the market cap of Lazard (LAZ)?

The market cap of Lazard (LAZ) is approximately 5.4B.
Lazard Ltd

NYSE:LAZ

LAZ Rankings

LAZ Stock Data

5.40B
91.97M
2.61%
92.37%
4.72%
Capital Markets
Investment Advice
Link
United States
NEW YORK